Characterizing the impact of CD8 antibodies on class I MHC multimer binding

Journal of Immunology

Volumn 174, Issue 7, 2005, Pages 3986-3991

  Holman, Philmore O ^a   Walsh, Elizabeth R ^a   Jameson, Stephen C ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MMC 334 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OKT 8; POLYMER;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 15444362931     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.7.3986     Document Type: Article

References (25)

1. Boniface, J. J., J. D. Rabinowitz, C. Wulfing, J. Hampl, Z. Reich, J. D. Altman, R. M. Kantor, C. Beeson, H. M. McConnell, and M. M. Davis. 1998. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 9:459.
2. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675.
3. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191:335.
4. Denkberg, G., C. J. Cohen, and Y. Reiter. 2001. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR. J. Immunol. 167:270.
5. Campanelli, R., B. Palermo, S. Garbelli, S. Mantovani, P. Lucchi, A. Necker, E. Lantelme, and C. Giachino. 2002. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation. Int. Immunol. 14:39.
6. Block, M. S., A. J. Johnson, Y. Mendez-Fernandez, and L. R. Pease. 2001. Monomeric class I molecules mediate TCR/CD3ε/CD8 interaction on the surface of T cells. J. Immunol. 167:821.
7. Lee, P. U., and D. M. Kranz. 2003. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells. Mol. Immunol. 39:687.
8. Dutoit, V., P. Guillaume, M. Ayyoub, C. S. Hesdorffer, I. F. Luescher, and D. Valmori. 2003. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate. J. Immunol. 170:5110.
9. Buslepp, J., S. E. Kerry, D. Loftus, J. A. Frelinger, E. Appella, and E. J. Collins. 2003. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC. J. Immunol. 170:373.
10. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353.
11. Devine, L., M. E. Hodsdon, M. A. Daniels, S. C. Jameson, and P. B. Kavathas. 2004. Location of the epitope for an anti-CD8α antibody 53.6.7 which enhances CD8α-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation. Immunol. Lett. 93:123.
12. Wooldridge, L., S. L. Hutchinson, E. M. Choi, A. Lissina, E. Jones, F. Mirza, P. R. Dunbar, D. A. Price, V. Cerundolo, and A. K. Sewell. 2003. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J. Immunol. 171:6650.
13. - T cells that express the same antigen-specific receptor. Proc. Natl. Acad. Sci. USA 98:1723.
14. Brock, R., K.-H. Weismuller, G. Jung, and P. Walden. 1996. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc. Natl. Acad. Sci. USA 93:13108.
15. Daniels, M. A., S. L. Schober, K. A. Hogquist, and S. C. Jameson. 1999. Cutting edge: a test of the dominant negative signal model for TCR antagonism. J. Immunol. 162:3761.
16. 227→Lys substitution in the acidic loop of major histocompatibility complex class I α3 domain distinguishes low avidity CD8 coreceptor and avidity enhanced CD8 accessory functions. J. Exp. Med. 184:1671.
17. Potter, T. A., T. V. Rajan, R. F. Dick, 2nd, and J. A. Bluestone. 1989. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 337:73.
18. Batard, P., J. Szollosi, I. Luescher, J. C. Cerottini, R. MacDonald, and P. Romero. 2002. Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations. Cytometry 48:97.
19. Choi, E. M., J. L. Chen, L. Wooldridge, M. Salio, A. Lissina, N. Lissin, I. F. Hermans, J. D. Silk, F. Mirza, M. J. Palmowski, et al. 2003. High avidity antigen-specific CTL identified by CD8-independent tetramer staining. J. Immunol. 171:5116.
20. Schott, E., and H. L. Ploegh. 2002. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells. Eur. J. Immunol. 32:3425.
21. Moody, A. M., Y. Xiong, H. C. Chang, and E. L. Reinherz. 2001. The CD8αβ co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci. Eur. J. Immunol. 31:2791.
22. Daniels, M. A., L. Devine, J. D. Miller, J. M. Moser, A. E. Lukacher, J. D. Altman, P. Kavathas, K. A. Hogquist, and S. C. Jameson. 2001. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation. Immunity 15:1051.
23. Tomonari, K., and S. Spencer. 1990. Epitope-specific binding of CD8 regulates activation of T cells and induction of cytotoxicity. Int. Immunol. 2:1189.
24. Ravichandran, K. S., and S. J. Burakoff. 1994. Evidence for differential intracellular signaling via CD4 and CD8 molecules. J. Exp. Med. 179:727.
25. Grebe, K. M., R. L. Clarke, and T. A. Potter. 2004. Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection. Proc. Natl. Acad. Sci. USA 101:10410.